Healing of a skin wound when using Trigonella foenum‑graecum against the background of experimental steroid hyperglycemia
https://doi.org/10.17709/2410-1893-2023-10-2-7
EDN: UCMZRS
Abstract
Purpose. To evaluate the intensity of healing of an infected skin wound in rats using Trigonella foenum- graecum (Fenugreek) against the background of experimental steroid hyperglycemia.
Materials and methods. The rats included in the study (n = 20) were divided into two equal groups. First, a model of steroid hyperglycemia was created for all animals. Then the same animals (n = 20) were used to create models of infected skin wound. The rats of the first group (the main one) were treated with wound surface ointment containing Trigonella foenum- graecum. Also, Trigonella foenum- graecum extract was constantly added to the water for the rats of the first group. Intact vaseline ointment was applied to the wound of the second group (control) rats. After 5 days, we evaluated the wound regeneration activity, blood glucose levels, and blood panel in all animals.
Results. This study showed several positive aspects of the use of Trigonella foenum-g raecum in terms of treatment of infected skin wounds in animals with steroid hyperglycemia. The decrease in glucose levels almost to baseline values in the rats of the main group against the background of oral administration of Trigonella foenum-g raecum was recorded. By the end of the observation, the level of glycemia was almost two times less in animals of the first group compared to the second (p < 0.05). In animals of the first group, the number of leukocytes was higher compared to the second group, but this difference was not significant. However, we recorded a significant increase in the number of granulocytes by more than two times (p < 0.05), which indicates the immunomodulatory property of Trigonella foenum- graecum, which affected the regeneration activity of the infected wound in a positive way in rats of the first group.
Conclusion. As a result of this study, promising prospects have been obtained for the use of the plant‑ derived drug Trigonella foenum- graecum in the correction of hyperglycemia and the treatment of infected wounds. Application of fenugreek topically in the form of an extract reduced inflammation and improved wound healing in rats suffering from steroid hyperglycemia.
About the Authors
L. A. BalykovaRussian Federation
Larisa A. Balykova – Corresponding member of RAS, Dr.Sci.(Med.), Professor, Director, Medical Institute, Ogarev National Research Mordovian State University, Saransk, Russian Federation
ORCID: https://orcid.org/0000-0002-2290-0013, SPIN: 2024-5807, AuthorID: 141643, Scopus Author ID: 6602093133
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
V. I. Inchina
Russian Federation
Vera I. Inchina – Dr. Sci. (Medicine), Professor, Head of the Department of Pharmacology and Clinical Pharmacology with the Course in Pharmaceutical Technology, Ogarev National Research Mordovian State University, Saransk, Russian Federation
ORCID: https://orcid.org/0000-0003-2218-1554, SPIN: 8616-6518, AuthorID: 331979, Scopus Author ID: 6603260213
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
T. V. Tarasova
Russian Federation
Tatyana V. Tarasova – Dr. Sci. (Biology), Professor at the Normal Physiology and Pathophysiology Department, Ogarev National Research Mordovian State University, Saransk, Russian Federation
ORCID: https://orcid.org/0000-0001-9745-9739, SPIN: 1726-3994, AuthorID: 96588, Scopus Author ID: 7005246518
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
G. I. Myandina
Russian Federation
Galina I. Myandina – Dr. Sci. (Biology), Professor at the Department of Biology and General Genetics of the Medical Institute, Peoples' Friendship University of Russia (RUDN University), Moscow, Russian Federation
ORCID: https://orcid.org/0000-0002-7613-326X, SPIN: 2635-2234, AuthorID: 90610, Scopus Author ID: 6505984492
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
D. A. Khaydar
Russian Federation
Dalila Khaydar – assistant of the Department of General Dentistry, Peoples' Friendship University of Russia (RUDN University), Moscow, Russian Federation
ORCID: https://orcid.org/0000-0002-5490-1037, SPIN: 3830-9356, AuthorID: 1056773
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
E. A. Korovyakova
Russian Federation
Elina A. Korovyakova – Cand. Sci. (Medicine), Associate Professor of the Department of General and Clinical Pharmacology of the Medical Institute, Peoples' Friendship University of Russia (RUDN University), Moscow, Russian Federation
ORCID: https://orcid.org/0000-0002-3149-8089, SPIN: 5031-8133, AuthorID: 351781, Scopus Author ID: 57201327585
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
L. M. Mosina
Russian Federation
Larisa M. Mosina – Dr. Sci. (Medicine), Professor, Head of the Department of Hospital Therapy, Ogarev National Research Mordovian State University, Saransk, Russian Federation
ORCID: https://orcid.org/0000-0001-6831-3116, SPIN: 2390-1111, AuthorID: 687543, Scopus Author ID: 26534703900
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
I. V. Saushev
Russian Federation
Igor V. Saushev – Dr. Sci. (Medicine), Professor of the Department of Anesthesiology and Resuscitation with courses in Valeology, Life Safety and Disaster Medicine, Ogarev National Research Mordovian State University, Saransk, Russian Federation
ORCID: https://orcid.org/0000-0001-6077-193X, SPIN: 1200-4091, AuthorID: 430327, Scopus Author ID: 6507348954
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
R. S. Tarasov
Russian Federation
Roman S. Tarasov – Associate Professor, Ogarev National Research Mordovian State University, Saransk, Russian Federation
ORCID: https://orcid.org/0000-0002-5598-5033, SPIN: 3358-5958, AuthorID: 618170
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
G. A. Bayburina
Russian Federation
Gulnar A. Bayburina – Dr. Sci. (Medicine), Associate Professor, Bashkir State Medical University of the Ministry of the Russian Federation, Ufa, Russian Federation
ORCID: https://orcid.org/0000-0002-4741-6295, SPIN: 4021-5801, AuthorID: 266985, Scopus Author ID: 57222630441
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
D. E. Bayburina
Russian Federation
Dina E. Bayburina – student, Bashkir State Medical University of the Ministry of the Russian Federation, Ufa, Russian Federation
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
I. E. Trubitsyna
Russian Federation
Irina E. Trubitsyna – Dr. Sci. (Medicine), Head of the Preclinical Research Laboratory, Loginov Moscow Clinical Scientific Center Moscow Department of Health, Moscow, Russian Federation
ORCID: https://orcid.org/0000-0002-1688-9866, SPIN: 2201-0486, AuthorID: 454543, Scopus Author ID: 6701679185
Competing Interests:
author declare that there are no obvious and potential conflicts of interest associated with the publication of this article.
References
1. 1 Javeed N, Matveyenko AV. Circadian Etiology of Type 2 Diabetes Mellitus. Physiology (Bethesda). 2018 Mar 1;33(2):138–150. https://doi.org/10.1152/physiol.00003.2018
2. 2 Balakhonova EA. Revention of late complications of diabetes mellitus: neuropathy and diabetic foot syndrome. Aktualnye issledovaniya. 2022;44(123):33–35. (In Russ.).
3. 3 Rachdaoui N. Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020 Mar 5;21(5):1770. https://doi.org/10.3390/ijms21051770
4. 4 Rao AS, Hegde S, Pacioretty LM, DeBenedetto J, Babish JG. Nigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study. J Med Food. 2020 Sep;23(9):905–919. https://doi.org/10.1089/jmf.2020.0075
5. 5 Pourkazemi A, Ghanbari A, Khojamli M, Balo H, Hemmati H, Jafaryparvar Z, Motamed B. Diabetic foot care: knowledge and practice. BMC Endocr Disord. 2020 Mar 20;20(1):40. https://doi.org/10.1186/s12902-020-0512-y
6. 6 Inchina V, Mutwakel H, Tarasova T, Ziaul Haq. Regeneration effect of an aqueous extract of Cymbopogon Proximus on infected wounds in a rodent model in steroid hyperglycemia. Archiv EuroMedica. 2020;10(2):35–37. https://doi.org/10.35630/2199-885x/2020/10/2.10
7. 7 Dharajiya D, Jasani H, Khatrani T, Kapuria M, Pachchigar K, Patel P. Evaluation of Antibacteria and Antifungal Activity of Fenugreek (Trigonella foenum-graceum) Extracts. Int J Pharm Sci. 2016;8:212–217.
8. 8 Bahmani M, Shirzad H, Mirhosseini M, Mesripour A, Rafieian-Kopaei M. A Review on Ethnobotanical and Therapeutic Uses of Fenugreek (Trigonella foenum-graceum L). J Evid Based Complementary Altern Med. 2016 Jan;21(1):53–62. https://doi.org/10.1177/2156587215583405
9. 9 Yadav UC, Baquer NZ. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol. 2014 Feb;52(2):243–254. https://doi.org/10.3109/13880209.2013.826247
10. 10 Wani S.A., Kumar P. Fenugreek: A review on its nutraceutical properties and utilization in various food products. J. Saudi Soc. Agric. Sci. 2018;17:97–106. https://doi.org/10.1016/j.jssas.2016.01.007
11. 11 Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Mol Nutr Food Res. 2017 Jun;61(6). https://doi.org/10.1002/mnfr.201600950
12. 12 Sharma V, Singh P, Rani A. Antimicrobial Activity of Trigonella foenum-graceum L. (Fenugreek). Eur J Exp Biol. 2017;7. https://doi.org/10.21767/2248-9215.100004
13. 13 Mahboubi M, Taghizadeh M, Khamechian T, Tamtaji OR, Mokhtari R, Talaei SA. The Wound Healing Effects of Herbal Cream Containing Oliveria Decumbens and Pelargonium Graveolens Essential Oils in Diabetic Foot Ulcer Model. World J Plast Surg. 2018 Jan;7(1):45–50.
14. 14 Reardon R, Simring D, Kim B, Mortensen J, Williams D, Leslie A. The diabetic foot ulcer. Aust J Gen Pract. 2020 May;49(5):250–255. https://doi.org/10.31128/ajgp-11-19-5161
15. 15 Güiza-Argüello VR, Solarte-David VA, Pinzón-Mora AV, Ávila-Quiroga JE, Becerra-Bayona SM. Current Advances in the Development of Hydrogel-Based Wound Dressings for Diabetic Foot Ulcer Treatment. Polymers (Basel). 2022 Jul 6;14(14):2764. https://doi.org/10.3390/polym14142764
16. 16 Shi C, Wang C, Liu H, Li Q, Li R, Zhang Y, et al. Selection of Appropriate Wound Dressing for Various Wounds. Front Bioeng Biotechnol. 2020 Mar 19;8:182. https://doi.org/10.3389/fbioe.2020.00182
17. 17 Ghotaslou R, Memar MY, Alizadeh N. Classification, microbiology and treatment of diabetic foot infections. J Wound Care. 2018 Jul 2;27(7):434–441. https://doi.org/10.12968/jowc.2018.27.7.434
18. 18 Kulchenko NG. Optimizing the conservative therapy of benign prostatic hyperplasia by inhibitors of 5–alfareductase. Clinical and morphological study. Kursk Scientific and Practical Bulletin "Man and His Health". 2012;1:101–106. (In Russ.).
19. 19 Kaprin AD, Kostin AA, Kulchenko NG. Optimization of drug therapy for benign prostatic hyperplasia. Urology and Andrology. 2013;2(1):5–9. (In Russ.).
20. 20 Kulchenko NG, Yatsenko EV. Phytotherapy for inflammatory diseases of the prostate. Research and Practical Medicine Journal (Issled. prakt. med.). 2019;6(3):87–97. (In Russ.). https://doi.org/10.17709/2409-2231-2019-6-3-8
21. 21 Asif M, Yousaf HM, Saleem M, Saadullah M, Chohan TA, Shamas MU, et al. Trigonella foenum-graecum Seeds Oil Attenuated Inflammation and Angiogenesis in vivo through Down-Regulation of TNF-α. Anticancer Agents Med Chem. 2021;21(11):1460–1471. https://doi.org/10.2174/1871520620666201005100132
22. 22 Mohammadi A, Gholamhosseinian A, Fallah H. Trigonella foenum-graecum water extract improves insulin sensitivity and stimulates PPAR and γ gene expression in high fructose-fed insulin-resistant rats. Adv Biomed Res. 2016 Mar 16;5:54. https://doi.org/10.4103/2277-9175.178799
23. 23 Robert SD, Ismail AA, Wan Rosli WI. Trigonella foenum-graecum seeds lowers postprandial blood glucose in overweight and obese individuals. J Nutr Metab. 2014;2014:964873. https://doi.org/10.1155/2014/964873
Supplementary files
Review
For citations:
Balykova L.A., Inchina V.I., Tarasova .V., Myandina G.I., Khaydar D.A., Korovyakova E.A., Mosina L.M., Saushev I.V., Tarasov R.S., Bayburina G.A., Bayburina D.E., Trubitsyna I.E. Healing of a skin wound when using Trigonella foenum‑graecum against the background of experimental steroid hyperglycemia. Research and Practical Medicine Journal. 2023;10(2):70-79. (In Russ.) https://doi.org/10.17709/2410-1893-2023-10-2-7. EDN: UCMZRS